6505--Famciclovir Tablets 36E79726R0017
Summary
AI-generated · Mar 09, 2026Procurement is an unrestricted, one-contract requirement for famciclovir tablets to support VA (including CMOPs and SVHs), DoD (TMOP), BOP, IHS, and FHCC programs. A single contractor will be awarded to provide an uninterrupted supply for the contract term, which runs for one year with four pre-priced option years, distributed through the VA and DoD Prime Vendor Programs. Offerors must specify the exact label name as it will appear on the product and must have a unique NDC; the contractor’s label will be the only label on the bottle, and VA labels must securely adhere on top of it (no label-over-label).
The product is famciclovir tablets in three strengths (125 mg, 250 mg, 500 mg), 30-count bottles, with estimated annual usage of 1,012, 10,522, and 13,642 bottles respectively. The solicitation will be issued electronically in commercial item format (FAR Part 12), with all documents downloadable from SAM.gov; there will be no paper copies. All responsible sources may submit offers, and the government will consider timely bids for award.
Pre-Solicitation Nadolol Tablets Page 1 of 2 Page 1 of 2 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0017 for an unrestricted procurement for Famciclovir Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of TriCare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. Solicitation # 36E79726R0017 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 23, 2026, with a tentative closing date of April 7, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to Richard.Mahario@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 Famciclovir 125mg Tablets 30 1,012 2 Famciclovir 250mg Tablets 30 10,522 3 Famciclovir 500mg Tablets 30 13,642
From Presolicitation posted on Mar 05, 2026N/A
From Solicitation posted on Mar 16, 2026Page 2 of 2 Extend the due date and time for receipt of offers. See Amendment document for details.
From Solicitation posted on Mar 25, 2026Notice history
3-
-
Solicitation Posted Mar 16, 2026View changes (4)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Mar 23, 2026 → Mar 30, 2026
- Set-Aside: None → None
-
Solicitation LATEST Posted Mar 25, 2026View changes (2)
- Description: Description was updated
- Response Deadline: Mar 30, 2026 → Apr 06, 2026
Details
Award Information
Contacts
Contract Specialist